Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
Many vaccine candidates with promising results in preclinical testing fail in human trials. New complex human tissue models have the potential to improve the predictability of vaccine safety and efficacy in human clinical trials.
Guardado en:
Autores principales: | David Komla Kessie, Thomas Rudel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e9a2bb220b045d4ae6e75a8ae2950f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deep sequencing and automated histochemistry of human tissue slice cultures improve their usability as preclinical model for cancer research
por: Susann Haehnel, et al.
Publicado: (2019) -
Preclinical Advances of Therapies for Laminopathies
por: Louise Benarroch, et al.
Publicado: (2021) -
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans
por: Kelly E. Seaton, et al.
Publicado: (2021) -
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
por: Nan Li, et al.
Publicado: (2021) -
Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
por: M. Tarek Elghetany, et al.
Publicado: (2021)